| Code | 24874 | ||||||||||
| MA number | 46/0263/15-S | ||||||||||
| Product Form: | cps dur 100x25 mg (blis.PVC/PVDC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.10.1995 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
DHCP_Neotigason_08 07 2016.pdf
|
| PIL: |
PIL_Neotigason_10 mg_25 mg_02.2024.pdf
|
| SPC: |
SPC_Neotigason_10 mg_25 mg_02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 30.05.2018 |
